相似文献
1
Response to comment on: Tessari et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62:2699-2708.
Diabetes. 2013 Oct;62(10):e24. doi: 10.2337/db13-1017.
2
Comment on: Tessari et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62:2699-2708.
Diabetes. 2013 Oct;62(10):e23. doi: 10.2337/db13-0891.
3
Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo.
Diabetes. 2013 Aug;62(8):2699-708. doi: 10.2337/db12-1127. Epub 2013 Mar 8.
4
ON NO--the continuing story of nitric oxide, diabetes, and cardiovascular disease.
Diabetes. 2013 Aug;62(8):2645-7. doi: 10.2337/db13-0542.
5
Nitric oxide and vascular insulin resistance.
Biofactors. 2009 Jan-Feb;35(1):21-7. doi: 10.1002/biof.3.
6
Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance.
Horm Metab Res. 2008 Sep;40(9):655-9. doi: 10.1055/s-0028-1083814. Epub 2008 Sep 15.
7
Impact of ADMA (asymmetric dimethylarginine) on physiology with respect to diabetes mellitus and respiratory system BEAS-2B cells (human bronchial epithelial cells).
J Pharm Pharmacol. 2013 Feb;65(2):253-63. doi: 10.1111/j.2042-7158.2012.01590.x. Epub 2012 Sep 26.
8
Asymmetric dimethylarginine: a molecule responsible for the coexistence of insulin resistance and atherosclerosis via dual nitric oxide synthase inhibition.
Med Hypotheses. 2005;65(6):1091-8. doi: 10.1016/j.mehy.2005.07.001. Epub 2005 Aug 26.
9
Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?
Diabetologia. 2002 Dec;45(12):1609-16. doi: 10.1007/s00125-002-0975-6. Epub 2002 Oct 30.
10
[Asymmetric dimethyl arginine (ADMA): a novel cardiovascular risk factor?].
Wien Med Wochenschr. 2007 Feb;157(3-4):57-60. doi: 10.1007/s10354-007-0373-2.
本文引用的文献
1
Comment on: Tessari et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62:2699-2708.
Diabetes. 2013 Oct;62(10):e23. doi: 10.2337/db13-0891.
2
Changing the way we think about endothelial cell insulin sensitivity, nitric oxide, and the pathophysiology of type 2 diabetes: the FoxO is loose.
Diabetes. 2013 May;62(5):1386-8. doi: 10.2337/db13-0183.
3
Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo.
Diabetes. 2013 Aug;62(8):2699-708. doi: 10.2337/db12-1127. Epub 2013 Mar 8.
4
Nitric oxide and peroxynitrite in health and disease.
Physiol Rev. 2007 Jan;87(1):315-424. doi: 10.1152/physrev.00029.2006.
5
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.
Anal Biochem. 1982 Oct;126(1):131-8. doi: 10.1016/0003-2697(82)90118-x.
Zotero 插件